Indicators of nonspecific immunity in cirrhosis and primary cancer of the liver

: The study of some factors of nonspecific immunity in 85 patients with cirrhosis and in 9 patients with primary cancer of the liver revealed a decrease of all factors of nonspecific immunity under consideration, while in primary cancer of the liver--selective and more sharp fall of properdin level. The complement, as compared with the control, was not changed, whereas lysozyme was statistically reliably higher than in healthy persons.